Navigation Links
NBTY To Web Cast Presentation at CL King Best Ideas Conference; Announces Preliminary Unaudited Net Sales Results For August 2009
Date:9/10/2009

RONKONKOMA, N.Y. Sept. 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will web cast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the CL King Best Ideas Conference in New York on Thursday, September 17, 2009.

The presentation is scheduled to be web cast live on NBTY's web site, (www.nbty.com) on Thursday, September 17, 2009 at 2:15PM Eastern Time.

NBTY's preliminary unaudited net sales results for August 2009 by segment are as follows:

                                       NET SALES
                              (Preliminary and Unaudited)
                                FOR THE MONTH OF AUGUST
                                     ($In Millions)

                                                 2009        2008     % Change
                                                 ----        ----     --------

    Wholesale / US Nutrition                     $148        $124          19%

    North American Retail                         $18         $17           2%

    European Retail                               $53         $44          20%

    Direct Response / E-Commerce                  $18         $18          -3%
                                                  ---         ---          ---

    Total                                        $236        $204          16%
                                                 ====        ====          ===

Leiner Health Products, which was acquired on July 14, 2008, has been fully integrated into the Wholesale / US Nutrition operations. North American Retail same store sales increased 2% for the one month period. European Retail net sales for August 2009 include $9 million from Julian Graves, which NBTY acquired on September 16, 2008. Without Julian Graves sales, European Retail net sales decreased 1%. In local currency (British Pound Sterling), excluding Julian Graves sales, European Retail net sales increased 14%.

NBTY's preliminary unaudited net sales results for the two months of July and August 2009 by segment are as follows:

                                       NET SALES
                             (Preliminary and Unaudited)
                          FOR THE TWO MONTHS JULY AND AUGUST
                                    ($In Millions)

                                                 2009        2008     % Change
                                                 ----        ----     --------

    Wholesale / US Nutrition                     $275        $230          20%

    North American Retail                         $34         $34           0%

    European Retail                              $108         $91          19%

    Direct Response / E-Commerce                  $37         $37          -1%
                                                  ---         ---          --

    Total                                        $454        $391          16%
                                                 ====        ====          ===

As previously stated, Leiner Health Products, which was acquired on July 14, 2008, has been fully integrated into the Wholesale / US Nutrition operations. North American Retail same store sales decreased 1% for the two-month period of July and August 2009. European Retail net sales for

the two-month period of July and August 2009 include $18 million from Julian Graves, which NBTY acquired on September 16, 2008. Without Julian Graves sales, European Retail net sales decreased 1%. In local currency (British Pound Sterling), excluding Julian Graves sales, European Retail net sales increased 16%.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl), LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

    Contact: Harvey Kamil                           Carl Hymans
             NBTY, Inc.                             G.S. Schwartz & Co.
             President & Chief Financial Officer    212-725-4500
             631-200-2020                           carlh@schwartz.com

'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Echo Therapeutics Announces New Presentation Time at Rodman & Renshaw 2009 Annual Global Investment Conference
2. Cell Therapeutics, Inc.s (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
3. Haemacure announces its presentation at the Rodman Renshaw 11th Annual Healthcare Conference
4. Volcano Corporation Presentation at Weisel Conference to be Webcast
5. Hospira Receives FDA Approval for Six New Presentations of Heparin
6. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
7. The Cosmetic Bootcamp LLC Announces Novel Presentations at Its 3rd Annual Marketing and Management Symposium
8. ColorAlchemy Presentation at 5th Largest Unity Church Reveals How Yellow Commands Greater Personal Power
9. Cepheid to Webcast Upcoming Financial Presentations
10. PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard(R) at ESC 2009 Has Been Published; Strong Preliminary Results Seen
11. NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for July 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: